Analyst Concerns Mount for Hims & Hers Growth Trajectory

The once-bright growth narrative for telehealth provider Hims & Hers is showing significant cracks. Market experts are now raising fundamental questions about the company’s future momentum, casting doubt on whether the stock can sustain its previous rally in the face of growing headwinds.

Significant Price Target Reduction Sparks Concern

In a notable shift in sentiment, Truist Securities has executed a substantial reduction in its price target for Hims & Hers. The investment bank slashed its target to $37 from $48, a move that signals deepening skepticism regarding the company’s prospects. While Truist maintained its “Hold” rating for the time being, the drastic cut clearly indicates that confidence in the established growth story is eroding.

Should investors sell immediately? Or is it worth buying Hims & Hers?

Core Growth Drivers Under Scrutiny

This pessimistic reassessment is rooted in specific and concrete worries over future revenue, with a particular focus on projections for 2026. Analysts highlighted a disappointing revenue outlook and assessed expectations for GLP-1-related sales in the latter half of the year as merely “moderate.” Furthermore, Truist analysts suggested that the recent acquisition of Zava will likely only be sufficient to help the company meet the lower end of its forecasts. They concluded that the deal does little to alleviate the more profound, fundamental concerns about long-term growth sustainability.

A Convergence of Negative Pressures

These analyst doubts have manifested in tangible market performance. The company’s shares declined approximately eight percent in a single week. This recent weakness compounds existing pressure on the stock, which is already navigating a tense market environment further burdened by substantial insider selling activity and the looming threat of class-action lawsuits. The question for investors is whether Hims & Hers can successfully counter this wave of skepticism or if the analysts’ gloomy forecast will prove accurate.